Lataa...
Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
OBJECTIVE: Sorafenib is a recommended treatment for advanced hepatocellular carcinoma. The study is to evaluate the efficacy of sorafenib plus cyproheptadine compared with sorafenib alone in patients with advanced hepatocellular carcinoma. METHODS: A retrospective cohort study reviewed all consecuti...
Tallennettuna:
| Julkaisussa: | Jpn J Clin Oncol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4376992/ https://ncbi.nlm.nih.gov/pubmed/25646358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyv007 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|